Harvard University researchers have found the diabetes drug Avandia can be harmful to heart and can lead to death. The study was led by Dr. Wolfgang Winkelmayer of Brigham and Women’s Hospital in Boston. He and his colleagues reported people aged 65 and older who took Avandia (rosiglitazone) had a 15 percent higher rate of death after an average of one year.
In November 2007, Avandia received a black box warning due to increased risk of heart attacks in diabetes patients. The drug increases the risk of heart attack by 40 percent, doubles the risk of heart failure and bone fractures and increases the risk of anemia and vision loss from macular edema.
However, the drug continues to be prescribed because the Food and Drug Administration concluded the inherent risk of heart attack wasn’t any greater than that associated with other similar medications.But the new study appearing in the Archives of Internal Medicine appears to contradict the FDA.
Source: eFlux Media
Filed under Diabetes, Diabetes Drug, Heart, NIDDM | Tags: Archives of Internal Medicine, Avandia, bone fractures, Food and Drug Administration, harmful to heart, macular edema, risk of anemia, risk of heart attacks | Comment Below